Type 2 Diabetes Medicines Exporter India to USA | City Drug House
City Drug House is a trusted exporter of Hepaglide 0.5 mg from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Hepaglide 0.5 mg injection is a, once-weekly subcutaneous prescription medication containing semaglutide, a GLP-1 receptor agonist designed for type 2 diabetes management and weight loss. It acts by mimicking natural hormones to increase insulin release, decrease glucagon secretion, and delay gastric emptying, promoting satiety.
Pharmacology of Hepaglide (Semaglutide) 0.5 mg :
Mechanism of Action: As a GLP-1 (Glucagon-Like Peptide-1) receptor agonist, it improves glycemic control by stimulating insulin secretion, reducing excessive sugar production in the liver, and slowing gastric emptying, which leads to increased fullness and reduced appetite.
Indication & Use: Used for improving blood sugar control in type 2 diabetes and supporting weight management in overweight/obese adults.
Administration: It is a once-weekly subcutaneous injection, typically administered in the abdomen, thigh, or upper arm.
Common Side Effects: Nausea, vomiting, diarrhea, stomach pain, constipation, and headache are common as the body adjusts.
Contraindications & Warnings: It should be used with caution in individuals with a history of pancreatitis, thyroid cancer, diabetic retinopathy, or severe gastrointestinal issues. It is not for use in Type 1 diabetes.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House is a trusted exporter of Hepaglide 0.5 mg from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Hepaglide 0.5 mg injection is a, once-weekly subcutaneous prescription medication containing semaglutide, a GLP-1 receptor agonist designed for type 2 diabetes management and weight loss. It acts by mimicking natural hormones to increase insulin release, decrease glucagon secretion, and delay gastric emptying, promoting satiety.
Pharmacology of Hepaglide (Semaglutide) 0.5 mg :
Mechanism of Action: As a GLP-1 (Glucagon-Like Peptide-1) receptor agonist, it improves glycemic control by stimulating insulin secretion, reducing excessive sugar production in the liver, and slowing gastric emptying, which leads to increased fullness and reduced appetite.
Indication & Use: Used for improving blood sugar control in type 2 diabetes and supporting weight management in overweight/obese adults.
Administration: It is a once-weekly subcutaneous injection, typically administered in the abdomen, thigh, or upper arm.
Common Side Effects: Nausea, vomiting, diarrhea, stomach pain, constipation, and headache are common as the body adjusts.
Contraindications & Warnings: It should be used with caution in individuals with a history of pancreatitis, thyroid cancer, diabetic retinopathy, or severe gastrointestinal issues. It is not for use in Type 1 diabetes.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
